GlassScriptPhysician profile
Todd Rimington
NPI 1144471160
$1,487.84
in general payments reported to CMS, 2019-2025
14 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $112 · 2021: $95.74 · 2022: $162 · 2023: $298 · 2024: $391 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979 · Consulting Fee: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $979.43 |
| Consulting Fee | $139.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lightbody Medical Technologies INC | $299.97 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $261.41 | 2020-2023 | Xiaflex |
| Orthofix Medical, INC. | $172.70 | 2020-2025 | Physio-Stim |
| Carbofix Orthopedics INC | $155.44 | 2020-2024 | |
| Acumed LLC | $145.10 | 2021-2025 | Acumed |
| Stryker Corporation | $137.99 | 2023-2024 | Hoffmann, Actishield |
| Endo USA, INC. | $117.82 | 2024-2025 | Xiaflex |
| Medwest Associates | $49.70 | 2022 | |
| Abbott Laboratories | $43.77 | 2024 | Proclaim, Eterna |
| Depuy Synthes Sales INC. | $30.07 | 2023 | Tfn-Advance, Lcp |
| Acera Surgical, INC. | $24.44 | 2024 | Restrata Wound Matrix |
| Arthrex, INC. | $24.00 | 2025 | |
| Convatec INC. | $20.74 | 2024 | |
| Dynasplint Systems INC. | $4.69 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Rimington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.